Please assess the completion status of the following clinical trial:

Trial Title: Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age ≥ 18 years~* diagnosis of cystic fibrosis as determined by sweat test or genotype and clinical symptoms~* clinically stable as determined by the investigator (pulmonologist)~Exclusion Criteria:~* intolerant to hypertonic saline.~* FEV1%p \<40% of predicted~* nursing mother~* positive urine pregnancy test~* unwilling to stop hypertonic saline therapy for 72 hours prior to each test day~* cigarette smoker (regular smoking within 6 months of study)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- isotonic saline then hypertonic saline (Type: ACTIVE_COMPARATOR): Subjects inhaled nebulized isotonic saline on study day 1, and then after a 5-24 day washout period, subjects inhaled nebulized 7% hypertonic saline on study day 2.
- hypertonic saline then isotonic saline (Type: ACTIVE_COMPARATOR): Subjects inhaled nebulized 7% hypertonic saline on study day 1, and then after a 5-24 day washout period, subjects inhaled nebulized isotonic saline on study day 2.

Based on this trial design, predict the completion outcome and termination type (if applicable).